glucose, (beta-d)-isomer has been researched along with Carcinoma, Renal Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Inzhevatkin, EV; Kurtasova, LM; Slepov, EV; Zukov, RA | 1 |
| Husney, RM; Rinehart, J; Sagone, AL; Triozzi, PL | 1 |
| Bogdanffy, MS; Knight, B; Ku, WW; Phillips, JA; Smith, JD; Taub, ME; Yuan, J | 1 |
| Chen, H; Kang, Q; Kuang, H; Liao, L; Shu, X; Wang, Y | 1 |
| Guo, P; Qin, F; Wang, Q; Wang, Y; Xing, Y; Yan, Y; Zeng, Q; Zhang, J | 1 |
| Bai, ZM; Huang, Y; Liu, ZX; Lv, C; Yu, D | 1 |
| Flaherty, L; Heilbrun, LK; Hussain, M; Ivy, P; Jain, V; LoRusso, PM; Vaishampayan, U | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Carcinoma, Renal Cell
| Article | Year |
|---|---|
A phase II study of rebeccamycin analog (NSC-655649) in metastatic renal cell cancer.
Topics: Adult; Aged; Aminoglycosides; Carbazoles; Carcinoma, Renal Cell; Confidence Intervals; Female; Glucosides; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Survival Rate | 2003 |
6 other study(ies) available for glucose, (beta-d)-isomer and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[Lymphocytes enzymatic status and peripheral blood neutrophils oxygen-dependent metabolism in patients with renal cancer].
Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Luminescent Measurements; Lymphocytes; Neutrophils; Oxygen; Zymosan | 2022 |
Interleukin-2 therapy enhances salicylate oxidation by blood granulocytes.
Topics: Carcinoma, Renal Cell; Cytotoxicity, Immunologic; Granulocytes; Humans; Hydrogen Peroxide; Immunity, Cellular; In Vitro Techniques; Interleukin-2; Killer Cells, Lymphokine-Activated; Oxidation-Reduction; Pentose Phosphate Pathway; Respiratory Burst; Salicylates; Tetradecanoylphorbol Acetate; Zymosan | 1991 |
Mode of action and human relevance assessment of male CD-1 mouse renal adenocarcinoma associated with lifetime exposure to empagliflozin.
Topics: Animals; Antigens, CD1; Benzhydryl Compounds; Carcinoma, Renal Cell; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Kidney; Kidney Neoplasms; Male; Mice; Rats; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Therapeutic Effect of Sodium Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Renal Cell Carcinoma.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Carcinoma, Renal Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glucose; Glucosides; Humans; Kidney; Kidney Neoplasms; Mice, Nude; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Down-Regulation; Emodin; Gene Expression Regulation, Neoplastic; Glucose; Glucosides; Glycolysis; Hexokinase; Humans; Kidney Neoplasms; Lactic Acid; Membrane Potential, Mitochondrial; Mitochondria; Signal Transduction | 2018 |
Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.
Topics: Animals; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Glucosides; Humans; Janus Kinase 2; Kidney Neoplasms; Male; Mice; Phenols; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2016 |